Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia
J Antimicrob Chemother
.
2021 Jan 1;76(1):270-271.
doi: 10.1093/jac/dkaa402.
Authors
Ella Trembizki
1
,
Amy V Jennison
2
,
Cameron Buckley
1
,
Amy Bright
3
,
Judith Holds
4
,
Alison Ward
5
,
John Pitt
6
,
Stella Pendle
7
,
Rob Baird
8
,
Kevin Freeman
8
,
Jenny Robson
9
,
Lebogang Mhango
1
,
Kym Lowry
1
,
Monica Lahra
10
11
,
David Whiley
1
12
Affiliations
1
The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
2
Public Health Microbiology, Forensic and Scientific Services, Health Support Queensland, Brisbane, Queensland, Australia.
3
Office of Health Protection, Australian Government Department of Health, ACT, Australia.
4
South Australia Pathology, Adelaide, South Australia, Australia.
5
Adelaide Sexual Health Centre, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
6
Adelaide City General Practice, South Australia, Australia.
7
Australian Clinical Labs, Bella Vista, New South Wales, Australia.
8
Royal Darwin Hospital, Darwin, Territory Pathology, Northern Territory, Australia.
9
Sullivan Nicolaides Pathology, Queensland, Australia.
10
World Health Organization Collaborating Centre for STI and AMR, Sydney, New South Wales, Australia.
11
University of New South Wales, Sydney, Australia.
12
Pathology Queensland Central Laboratory, Brisbane, Australia.
PMID:
33020835
DOI:
10.1093/jac/dkaa402
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Australia / epidemiology
Gonorrhea* / diagnosis
Gonorrhea* / epidemiology
Humans
Neisseria gonorrhoeae